This provider's $25.7M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 59% from 2015 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 171% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2015 | $59.20 | $16.79 | 3.53x | $42.41 | $584.3K | 37.1K | 25.6K |
| 2016 | $107.10 | $32.75 | 3.27x | $74.35 | $1.6M | 47.9K | 27.0K |
| 2017 | $169.86 | $51.89 | 3.27x | $117.97 | $1.2M | 11.8K | 6.5K |
| 2018 | $294.59 | $144.25 | 2.04x | $150.34 | $2.3M | 12.7K | 6.5K |
| 2019 | $144.80 | $73.20 | 1.98x | $71.60 | $4.6M | 30.5K | 13.5K |
| 2020 | $84.30 | $59.18 | 1.42x | $25.12 | $7.0M | 54.5K | 24.9K |
| 2021 | $48.42 | $33.02 | 1.47x | $15.40 | $5.0M | 52.5K | 25.0K |
| 2022 | $45.77 | $26.04 | 1.76x | $19.73 | $2.6M | 50.8K | 33.1K |
| 2023 | $35.34 | $22.99 | 1.54x | $12.35 | $927.9K | 36.6K | 25.6K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 55.6K | $12.4M | $223.02 | 2.01x |
| 80307 | Testing for presence of drug | 54.1K | $3.3M | $61.43 | 1.78x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 29.5K | $2.6M | $89.10 | 2.15x |
| G0482 | Drug test def 15-21 classes | 13.9K | $2.6M | $188.32 | 1.66x |
| G0480 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 9.3K | $1.1M | $112.97 | 1.48x |
| G0481 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 3.6K | $549.0K | $151.48 | 1.61x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 10.9K | $272.5K | $24.93 | 2.07x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 5.4K | $254.6K | $47.26 | 3.10x |
| 82542 | Chemical analysis using chromatography technique | 8.7K | $135.6K | $15.54 | 3.40x |
| 83789 | Mass spectrometry (laboratory testing method) | 8.7K | $135.0K | $15.54 | 3.16x |
| 87631 | Detection test for multiple types of respiratory virus | 851 | $121.2K | $142.46 | 1.03x |
| 87798 | Detection test for organism | 3.0K | $104.4K | $35.34 | 1.39x |
| 87633 | Detection test for multiple types of respiratory virus | 220 | $99.8K | $453.83 | 1.78x |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 8.4K | $98.5K | $11.76 | 1.18x |
| 87640 | Detection test for Staphylococcus aureus (bacteria) | 2.6K | $92.3K | $35.33 | 1.39x |
| 84311 | Chemical analysis using spectrophotometry (light) | 9.2K | $85.3K | $9.32 | 3.20x |
| 87653 | Detection test for Strep (Streptococcus, group B) | 2.0K | $70.7K | $35.11 | 1.55x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 3.7K | $60.8K | $16.53 | 1.55x |
| 82570 | Creatinine level to test for kidney function or muscle injury | 9.6K | $59.4K | $6.16 | 3.29x |
| 82306 | Vitamin d-3 level | 1.9K | $54.9K | $29.14 | 1.56x |
This provider submits charges 1.97 times higher than what Medicare actually pays.
A markup ratio of 1.97x means for every $100 Medicare pays, this provider initially charges $197. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in MI for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Vpa Pc | Troy, MI | $119.3M | ✓ Clear |
| Biotech Clinical Laboratories Inc | Novi, MI | $89.7M | ✓ Clear |
| Orchard Laboratories Corp | West Bloomfield, MI | $78.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data